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Background: White adipose tissue is recognized as a highly active organ, which is closely related to a large number of
physiological and metabolic processes besides storing triglycerides. However, little is known regarding the response of
adipose tissue to acute inflammation. Therefore, in this study we employed growing pigs to investigate the changes of
lipid metabolism and proteome in white adipose tissue after lipopolysaccharide (LPS) stimulation as a model for bacterial
infection.
Methods: The expression of lipid metabolism and inflammation related genes was determined by quantitative real-time
polymerase chain reaction. Label-free proteomics analysis was used to investigate changes of the protein profile in white
adipose tissue and western blot was used to verify changes of selected adipokines.
Results: The results indicated that LPS significantly increased the expression of toll-like receptor (TLR) 2/4 pathway-related
genes and pro-inflammatory factors. Lipid metabolism related genes, including acetyl-CoA carboxylase 1 (ACACA), fatty
acid synthase (FASN), stearoyl-CoA desaturase (SCD), uncoupling protein 2 (UCP2), and 11 β-hydroxysteroid
dehydrogenase type 1 (11β-HSD1), were down-regulated and the lipolytic enzyme activity was decreased after
LPS injection. Proteome analysis revealed 47 distinct proteins with > 2-fold changes. The down-regulation of
two proteins (cAMP-dependent protein kinase type II-alpha regulatory subunit and β-tubulin) has been verified
by western blot analysis. In addition, the abundance of two adipokines (adiponectin and zinc-α2-glycoprotein)
was significantly increased after LPS injection.
Conclusion: In conclusion, LPS challenge can cause acute inflammation in white adipose tissue. Concurrently,
lipid metabolism was significantly suppressed and the abundance of several proteins changed in white adipose
tissue. The results provide new clues to understand the adipose dysfunction during inflammation.
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In the traditional view, white adipose tissue (WAT) in
mammals was seen as the main site for energy storage.
However, this view changed since more and more stud-
ies demonstrated that WAT is not only a passive storage
of triglycerides but also a highly dynamic organ which is
closely related to a large number of physiological and
metabolic processes [1]. WAT actively participates in
body energy regulation through a network of endocrine,* Correspondence: yangxj@njau.edu.cn
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creativecommons.org/publicdomain/zero/1.0/paracrine and autocrine signals [2]. Recent researches
suggest that adipocytes are also immunologically active,
and may play an important role in host defense [3–5].
At present, humans and animals frequently suffer from
inflammation, which can be induced by bacterial infec-
tion, especially by gram-negative bacteria [6]. Obesity, as
one of the most serious health risks, is always associated
with low-degree inflammation [7]. However, most of the
investigations concerning inflammation focus on immu-
nocytes or immune organs [8], only a minority of re-
searchers pay attention to WAT in this regard [9–11]. In
those studies, changes in the gene expression profile of
human adipose tissue after acute inflammation werele distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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acute inflammation induces signs of inflammation and
changes in lipoprotein metabolism in the adipose tissue
of cats [10]. Meanwhile, it has been demonstrated that
fat depots are differently sensitive to lipopolysaccharide
(LPS) stimulation as indicated by nuclear factor-κB (NF-
κB) activation [12]. LPS is the major component of the
outer membrane in gram-negative bacteria [13] and it
can cause acute inflammation resulting eventually in all
kinds of pathophysiological damages [14]. LPS injection
was used in the present study to simulate bacterial infec-
tion and to study inflammation-induced changes in lipid
metabolism and in the proteome of WAT.
In recent years, following the rapid development of
mass spectrometry, proteomics analysis has been fre-
quently used as a very powerful bioanalytical method for
solving various scientific problems from medicine, biol-
ogy and biochemistry [15]. Especially, label-free proteo-
mics analysis has emerged as a high-throughput method
for quantitative clinical proteome studies. Therefore,
label-free proteomics analysis was used in the present
study to determine changes of the protein profile in
WAT of growing pigs after LPS stimulation. Together
with observed changes in lipid metabolism, the results
may provide a promising clue to metabolic and inflam-
matory responses leading to the development of adipose
tissue dysfunction.Results
Expression of genes involved in toll-like receptor 2 and 4
pathway and inflammatory cytokines
As shown in Fig. 1, the gene expression of toll like re-
ceptor 2 (TLR2), TLR4, and NF-κB p65 were all signifi-
cantly increased after LPS stimulation for 6 h. Similarly,
the gene expression of inflammatory cytokines, such as
tumor necrosis factor-α (TNF-α), interleukin-1α (IL-1α),Fig. 1 Toll-like receptor pathway and pro-inflammatory factors gene
expression after LPS injection compared to control. Data represent
the means ± SEM. Data were considered statistically significant when
P < 0.05, n = 6. *represent P < 0.05, **represent P < 0.01IL-1β, and IL-6 was also higher (P < 0.05) in LPS stimu-
lated animals compared to controls.Expression of genes involved in lipid metabolism
As shown in Fig. 2, the gene expression of key enzymes
of lipogenesis, including acetyl-CoA carboxylase 1
(ACACA), fatty acid synthase (FASN), and stearoyl-CoA
desaturase (SCD), decreased after LPS treatment (P < 0.05).
The gene expression of key enzymes of lipolysis, including
hormone-sensitive lipase (HSL) and adipose triglyceride lip-
ase (ATGL), remained unchanged (P > 0.05). However, as
shown in Fig. 2b, the activity of these key enzymes in lipoly-
sis was lower in the LPS injected animals. The gene expres-
sion of carnitine palmitoyltransferase-1A (CPT-1A), which
is the key enzyme in β-oxidation, was significantly increased
in the LPS stimulated group, while the gene expression of
uncoupling protein 2 (UCP2) was decreased. The gene
expression of 11 β-hydroxysteroid dehydrogenase type 1
(11β-HSD1) showed a trend to lower values in the LPS
group.Label-free quantitative proteomics analysis
Table 1 specifies 47 proteins which showed at least a 2-
fold change between the two groups. The proteins wereFig. 2 Lipid metabolism gene expression and lipolytic enzymes activity
after LPS injection compared to control. a Relative mRNA abundance of
ACACA, FASN, SCD, HSL, ATGL, CPT-1A, UCP2, UCP3, and 11β-HSD1. b
Lipolytic enzymes activity. Data represent the means ± SEM. Data
were considered statistically significant when P < 0.05, n = 6.
# represent P < 0.1, *represent P < 0.05, **represent P < 0.01
Fig. 3 The classification and heat map of distinct proteins in label-free proteomics analysis. a The classification of distinct proteins. b The heat
map of distinct proteins
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(Fig. 3a). In Fig. 3b, the heat map of the 47 distinct
proteins is shown. The volcano plot and radar chart
are shown in Additional file 1: Figure S1 and Additional
file 2: Figure S2. The results indicate that cAMP-
dependent protein kinase type II-alpha regulatory subunit
(PRKAR2A) and β-tubulin (TUBB) were significantly
down-regulated following the administration of LPS. Theresults could be confirmed by western blot analysis
(Fig. 4).
mRNA and protein levels of selected adipokines
As shown in Fig. 5, mRNA abundances of leptin, adipo-
nectin, and zinc-α2-glycoprotein (ZAG) were not differ-
ent between control and LPS group. Furthermore, the
protein content of leptin remained unchanged after LPS
Table 1 Regulated proteins after LPS injection identified with label-free proteomics analysis
Number Name Gene symbol Protein Name Difference
1 C1PIG4;P05207 PRKAR2A cAMP-dependent protein kinase type II-alpha regulatory
subunit
down
2 F1RGP1 MYBBP1A Uncharacterized protein down
3 F1RI43;P16960 RYR1 Ryanodine receptor 1 down
4 F1RJ89 RGCC Uncharacterized protein down
5 F1RLG5 REEP5 Uncharacterized protein down
6 F1RMP2 DNHD1 Uncharacterized protein down
7 F1RSP5 LOC100524618 Uncharacterized protein down
8 F1RUN2;P08835;CON__P02768-1 ALB Serum albumin down
9 F1RVZ1 ACOX1 Uncharacterized protein down
10 F1RWH6 CDK5RAP3 Uncharacterized protein down
11 F1RX84 PROSC Uncharacterized protein down
12 F1RYS5 SEPT11 Uncharacterized protein down
13 F1S0A2 LOC100737887 Peptidyl-prolyl cis-trans isomerase down
14 F1S1X9 TXNL1 Uncharacterized protein down
15 F1S340 SRI Uncharacterized protein down
16 F1S458 KARS Lysine–tRNA ligase down
17 F1S4Y0 ACSS2 Uncharacterized protein down
18 F1S8H8 PNP Uncharacterized protein down
19 F1S8J6 RAB2B Uncharacterized protein down
20 F1S9A4 NUCB2 Uncharacterized protein down
21 F1S9C9 LOC100155139 Proteasome subunit beta type down
22 F1SAN6 ILVBL Uncharacterized protein down
23 F1SBT8 ACSBG2 Uncharacterized protein down
24 F1SEQ7 FAM213A Uncharacterized protein down
25 F1SF47 HSD11B1 Uncharacterized protein down
26 F1SNL7;I3LV33 LOC100621569 Uncharacterized protein down
27 F1STR1 CTSC Uncharacterized protein down
28 F2Z528 PSMA4 Proteasome subunit alpha type down
29 F2Z5D2 ACTR3 Uncharacterized protein down
30 F2Z5G9 SNRPD1 Uncharacterized protein down




33 I3L5C8 LOC100623824 Uncharacterized protein down
34 I3L883 GCKR Uncharacterized protein down




37 I3LCZ7;F1RRW8 N/A/DNM1 Uncharacterized protein down
38 I3LJE2;I3LN38 DPYSL2/CRMP1 Uncharacterized protein down
39 I3LM05 N/A Uncharacterized protein down
40 I3LR71 ELOVL5 Elongation of very long chain fatty acids protein down
41 I3LU39 ISG15 Uncharacterized protein up
42 K7GQX0;F1SKU5;K7GM70;K7GL83;F1S585;K7GP99 ILF3/STRBP Uncharacterized protein down
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Table 1 Regulated proteins after LPS injection identified with label-free proteomics analysis (Continued)
43 Q06AS8 GNAI3 GBAK down
44 Q19PY3;F2Z5V0 RTCB tRNA-splicing ligase RtcB homolog down
45 Q2TJA5 AKR1C4 Aldo-keto reductase down
46 Q767L7 TUBB Tubulin beta chain down
47 Q7YQ94;P15981 SLA-DQA1/N/A MHC class II antigen/SLA class II histocompatibility
antigen, DQ haplotype D alpha chain
down
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and ZAG were significantly increased in the LPS group.
Discussion
Research on inflammation in human and animals usually
focuses on immune system, lung, and kidney etc. which
are always regarded as targets for drugs to alleviate the
inflammation and recover the health [16–22]. Although
WAT has already been recognized as a highly active
endocrine organ, its response to inflammation is still un-
clear. Therefore, this study was conducted to investigate
changes of lipid metabolism and proteome of adipose
tissue after LPS stimulated inflammation in growing
pigs. Recent studies have shown that LPS can induce a
systemic inflammation [23]. In recognition of the bacter-
ial LPS by host animals and humans, pattern recognition
receptors such as toll-like receptors play a critical role in
the innate immune system [24]. Ajuwon et al. demon-
strated that LPS could induce NF-κB p65 nuclear trans-
location and increased the expression of IL-6 and IL-15
in pig adipocytes [25]. Our results accordingly showed
that LPS activated the TLR pathway, upregulated the
expression of pro-inflammatory factors, and eventually
resulted in the inflammation of adipose tissue.
It is well known that the metabolic status of WAT it-
self plays an important role in the process of storing en-
ergy. Lipogenesis and lipolysis are two most basic and
important processes in lipometabolism of WAT. Key en-
zymes in the processes of lipogenesis are, among others,
ACACA, FASN, and SCD. Furthermore, HSL and ATGL
both play an important role in lipolysis [26]. In our
study, the gene expression of ACACA, FASN, and SCD
was decreased and the activity of the key enzymes of lip-
olysis (mainly HSL and ATGL) was also depressed after
LPS challenge. The results suggest that the acute inflam-
mation, which LPS caused, could suppress metabolic ac-
tivity in adipose tissue. CPT-1 initiates the translocation
of long chain fatty acids across the mitochondrial mem-
branes for beta-oxidation [27, 28]. The uncoupling pro-
tein family is a mitochondrial anion carrier family and
plays an important role in the biological traits of animal
body weight, basal metabolic rate, and energy conversion
[29]. After LPS stimulation, although the expression
of CPT-1A increased significantly, UCP2 and UCP3 ex-
pression was decreased. This result demonstrated thatenergy expenditure is low in adipose tissue in the condi-
tion of acute inflammation. The results proved the effect
of LPS on the suppression of metabolic activity.
Our results demonstrated that the expression of a var-
iety of lipid metabolism genes significantly changed after
LPS stimulation. Therefore, we employed label-free pro-
teomics analysis to investigate protein changes in WAT.
All the distinct proteins were shown in the volcano plot
and they were obviously separated from the other pro-
teins. In the radar chart, we can clearly see the extent of
change for each distinct protein. According to the results
of proteome, from all detected differentially expressed
proteins, 23.4 % were related to protein metabolism,
14.9 % to fat metabolism, and 12.8 % to energy metabol-
ism. In general, 51.1 % of the detected proteins were
metabolism-related. Based on the results of this study, it
is obvious that metabolism in white adipose tissue was
seriously affected by LPS stimulation, particularly pro-
tein metabolism. These results may help to better under-
stand the relationship between the inflammation and the
development of metabolic disorders in white adipose tis-
sue. The proteome data showed that the expressions of
acyl-CoA synthetase short-chain family member 2
(ACSS2), acyl-CoA synthetase bubblegum family mem-
ber 2 (ACSBG2) and ELOVL fatty acid elongase 5
(ELOVL5) were all decreased after LPS stimulation.
These three proteins are associated with lipogenesis
[30–32]. It is well-known that LPS influences immune
response [33]. Accordingly, our results revealed 10.6 %
of the regulated proteins were immune-related. It is very
interesting to note that the proteins involved in ion
channel were also influenced and they account for
10.6 % of regulated proteins. Among the 47 proteins that
were identified, the levels of only 1 protein increased,
whereas the levels of the remaining 46 proteins de-
creased significantly following LPS administration. Previ-
ous studies have demonstrated that total protein
synthesis is reduced in response to adverse conditions,
which relieves the burden imposed on the protein qual-
ity control system [34]. Additionally, the pausing of ribo-
somal elongation may be involved [35]. Their results
may partly explain why adipose tissue protein decreased
in the present study.
Among these detected proteins, 11 β-HSD1 is a key
enzyme which can convert inactive glucocorticoid into
Fig. 4 The protein abundance of PRKAR2A and TUBB after LPS
injection compared to control. a The protein abundance of
PRKAR2A. b The protein abundance of TUBB. Representative parts of
western blots are shown above the graph. Data represent the
means ± SEM. Data were considered statistically significant when
P< 0.05, n= 6. # represent P < 0.1, * represent P < 0.05, ** represent P < 0.01
Fig. 5 Adipokines gene expression and protein abundance after LPS inj
adiponectin and ZAG. b-d Leptin, adiponectin, and ZAG protein abund
graph. Data represent the means ± SEM. Data were considered statistica
P < 0.05, **represent P < 0.01
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portant amplifier of glucocorticoid activity in peripheral
tissues [37]. Several studies have demonstrated that 11
β-HSD1 is a powerful regulator in modulating WAT me-
tabolism and function [38]. Our results indicated a trend
to decreased mRNA expression of 11β-HSD1 in the LPS
group and also significantly decreased protein expres-
sion. In all eukaryotic cells, microtubules, which are
integral components of the cytoskeleton, are highly dy-
namic long filamentous structures which play a key role
in some cellular processes, such as cell division, cell
migration and support of cell shape and polarity [39].
Microtubules are protein polymers in the form of hollow
cylindrical filaments, composed of α- and β- tubulin
heterodimers [40, 41]. As we all know, β-tubulin is very
stable in most cases, therefore, it is often used as
reference gene. However in this study, we found the
expression of β-tubulin obviously decreased after LPS
stimulation according to the analysis of proteome.
Chakravortty et al. reported that LPS can cause the
disorganization of actin, tubulin and vimentin in bovine
aortic endothelial cells [42], which is in concordance
with our result. It is well-known that the intracellular
target of cAMP is the cAMP-dependent protein kinase
(PKA). The inactive PKA holoenzyme is a tetramer con-
sisting of two regulatory (R) and two catalytic (C) sub-
units; and PRKAR2A is cAMP-dependent protein kinase
type II-alpha regulatory subunit [43]. Our results of
proteome analysis and verified by western blot revealed
that the protein expression of PRKAR2A was extremely
decreased after LPS stimulation.ection compared to control. a Relative mRNA abundance of leptin,
ance. Representative parts of western blots are shown above the
lly significant when P < 0.05, n = 6. # represent P < 0.1, *represent
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role on the regulation of inflammation by secreting vari-
ous adipokines. However, our results of proteome ana-
lysis did not indicate that adipokines were regulated.
Thus, we selected three of the most studied adipokines,
namely leptin, adiponectin and ZAG, to investigate the
contribution of WAT to systemic inflammation. The pri-
mary role of leptin is control of appetite while it also has
an effect on regulating immunity [44, 45]. It can protect
T lymphocytes from apoptosis, regulates T-cell prolifera-
tion and influences cytokines production from T lym-
phocytes [46]. Gualillo et al. found that inflammation
can induce elevation of plasma leptin concentration in
rats [47]. Accordingly, Sarraf et al. demonstrated that
after administration of Escherichia coli LPS, leptin gene
expression and leptin levels were increased [48]. How-
ever, our results revealed no difference in leptin expres-
sion after LPS stimulation. The reason may be the time
of sampling and the dose of LPS stimulation. Adiponec-
tin is best known for its role in the regulation of insulin
sensitivity [49]. Recently, scientists demonstrated that
adiponectin has the function of anti-inflammation as it
can reduce the production and activity of TNF-α and IL-
6 [50]. Besides, it can also induce the anti-inflammatory
cytokines IL-10 and IL-1 receptor antagonist [51–53].
This may contribute to overcome inflammation in an
infected organism. In our study, the expression of adipo-
nectin increased under the condition of inflammation.
Iwasa et al. found that serum adiponectin levels signifi-
cantly increased at 6 h or 24 h after the injection of LPS
[54], which is consistent with our results. ZAG is an-
other adipokine and its overexpression occurs in all
kinds of malignant tumors [55], thus, it is now recog-
nized as a cancer marker. However, the biological
functions of ZAG are largely unknown. According to
the recent researches, ZAG can induce lipolysis by ac-
tivating hormone-sensitive lipase and its activity is
mainly mediated via the β3 adrenoreceptor with up-
regulation of the cAMP pathway [56]. Its effect on in-
flammation is still widely unclear. In 2005, Boat et al.
found that LPS can significantly increase the gene ex-
pression of ZAG in human adipocytes at the doses of
10 ng/mL and 100 ng/mL [57]. In the present study
we found ZAG protein expression increased after LPS
stimulation suggesting an association with inflamma-
tion of adipose tissue.
Conclusion
LPS injection caused acute inflammation response in white
adipose tissue. Most of lipid metabolism related genes were
significantly influenced and 47 proteins demonstrated
2-fold changes in white adipose tissue in the condition
of acute inflammation. Simultaneously, two adipokines,
adiponectin and ZAG protein content were significantlyincreased. The results provide new clues to understand the
adipose dysfunction during inflammation.
Materials and methods
Ethics statement
The experiment was conducted following the guidelines
of Animal Ethics Committee at Nanjing Agricultural
University, China. The euthanasia and sampling proce-
dures complied with the “Guidelines on Ethical Treat-
ment of Experimental Animals” (2006) No. 398 set by
the Ministry of Science and Technology, China and “the
Regulation regarding the Management and Treatment of
Experimental Animals” (2008) No. 45 set by the Jiangsu
Provincial People’s Government.
Animals and experimental design
Twelve Duroc × (Landrace × Large White) male pigs
from Huaian commercial farm of similar age and weight
(12 ± 0.5 kg) were used in this experiment. The pigs
were randomly divided into a control group and a lipo-
polysaccharide (LPS) injected group. They were fed
thrice a day with a commercial pig diet for growing pigs.
Water was available ad libitum. This study was con-
ducted at the Jiangsu Academy of Agricultural Sciences.
Before starting the experiment, all the pigs were
allowed to adapt to the environment for one week. After
adaptation, the pigs of the LPS group (n = 6) were
injected intramuscularly with LPS (E. coli serotype,
Sigma Aldrich Ireland, Ltd) at a dose of 15 μg/kg body
weight. The remaining pigs (n = 6) received an equiva-
lent volume of physiological saline at the same time. Six
hours after LPS injection, the pigs were sacrificed by ex-
sanguination. Back fat samples were collected and frozen
in liquid nitrogen, finally stored at -70 °C.
RNA isolation, cDNA synthesis and real-time PCR
Total RNA was extracted from back fat samples with
Total RNA Isolation Reagent (3101-100, Shanghai Pufei
Biotech). Quantity of the RNA was measured by Nano-
Drop ND-1000 spectrophotometer (Thermo, USA). The
ratios of absorption (260/280 nm) of all samples were
between 1.8 and 2.0. Aliquots of RNA samples were sub-
jected to electrophoresis using a 1.4 % agarose–formal-
dehyde gel to verify RNA integrity. Two micrograms of
total RNA were treated with RNase-free DNase (M6101,
Promega, USA) and reverse-transcribed according to the
manufacturer’s instructions. Two microliters of diluted
cDNA (1:20, vol/vol) were used for real-time PCR which
was detected in Mx3000P (Stratagene, USA). All the
primers were designed with the software “Primer Prem-
ier 6” and then blasted in NCBI. Peptidylprolyl isomer-
ase A (PPIA), which is not affected by the experimental
factors (LPS), was chosen as the reference gene. All the
primers chosen to study the expression of genes related
Table 2 Primer sequences for real-time PCR amplification
Target genes Reference/GenBank accession Primer sequences
TLR2 NM_213761.1 F: GACACCGCCATCCTCATTCT R: CTTCCCGCTGCGTCTCAT
TLR4 AB188301.2 F: TCTACATCAAGTGCCCCTAC R: TAAATTCTCCCAAAACCAAC
NF-κB p65 KC316023.1 F: GGGGACTACGACCTGAATGC R: CACGGTTGTCAAAGATGGG
TNF-α X57321.1 F: CCACGCTCTTCTGCCTACTGC R: TCGGCTTTGACATTGGCTACAA
IL-1α NM_214029.1 F: TACTGACTATGGCTACCAA R: ATTCCAGCTGCTATTGTG
IL-1β AY291592.1 F: CCGCCAAGATATAACTGAC R: GCAGCAACCATGTACCAA
IL-6 AF518322.1 F: AATGCTCTTCACCTCTCC R: CACACTTCTCATACTTCTCAC
ACACA NM_001114269.1 F: GGCCATCAAGGACTTCAACC R: ACGATGTAAGCGCCGAACTT
FASN NM_001099930.1 F: GTCCTGCTGAAGCCTAACTC R: TCCTTGGAACCGTCTGTG
SCD NM_213781.1 F: CTACACAACCACCACTACCATCAC R: GCAAACGCCCAGAGCAAGG
HSL HM591297.1 F: ACCCTCGGCTGTCAACTTCTT R: TCCTCCTTGGTGCTAATCTCGT
ATGL EU373817.1 F: ACCTGTCCAACCTGCTGC R: GCCTGTCTGCTCCTTTATCCA
CPT-1A NM_001129805.1 F: ACAACGAGGTCTTCCGAT R: AACGCAAAACCACCAAACCC
UCP2 NM_214289.1 F: GACGCCTACAAGACCATC R: CTCAGCACAGTTGACAATG
UCP3 NM_214049.1 F: GACGATGGATGCCTACAG R: CACCTTCTCCTTGATGACA
11β-HSD1 NM_214248.1 F: CCATGCTGAAGCAGAGCAAC R: AAGAACCCGTCCAGAGCAAA
ZAG XM_003124307.2 F: GCAGCCGTGAACACCAAGC R: GGTACCTCCGCAGCATCCC
adiponectin EF601160.1 F: CCGTTCAGCATTCAGTGT R: CAGCCTTGTCCTTCTTGTA
leptin NM_213840.1 F: CATCCATTGTTCGCTGTG R: CTGTCCTCTCCATTAGTCTC
PPIA JX523418.1 F:GACTGAGTGGTTGGATGG R:TGATCTTCTTGCTGGTCTT
TLR2 toll-like receptor 2, NF-κB p65 nuclear factor-kappa B p65, TNF-α tumor necrosis factor-α, IL-1α interleukin-1α, ACACA acetyl-CoA carboxylase alpha, FASN fatty
acid synthase, SCD stearoyl-CoA desaturase, HSL hormone-sensitive lipase, ATGL adipose triglyceride lipase, CPT-1A carnitine palmitoyltransferase 1A, UCP2 uncoupling protein
2, 11β-HSD1 hydroxysteroid (11-beta) dehydrogenase 1, ZAG zinc-α2-glycoprotein, PPIA Peptidylprolyl isomerase A
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Table 2, were synthesized by Generay (Shanghai, China).
The method of 2−ΔΔCt was used to analyze the real-time
PCR results and gene mRNA levels were expressed as
the fold change relative to the mean value of control
group (Livak and Schmittgen, 2001).Adipose tissue preparation, total protein extraction and
western blot
Frozen back fat samples (400 mg each) were minced and
homogenized in 2 mL each of ice-cold homogenization
buffer RIPA containing the protease inhibitor cocktail
(Complete EDTA-free, Roche, Penzberg, Germany). Protein
concentration was determined using a BCA Protein Assay
kit (Pierce, Rockford, IL, USA). Forty micrograms of
protein extract from each sample were then loaded
onto 7.5 % SDS-PAGE gels and the separated proteins
were transferred onto nitrocellulose membranes (Bio
Trace, Pall Co, USA). After transfer, membranes were
blocked for 2 h at room temperature in blocking
buffer and then membranes were incubated with the
primary antibodies, in dilution buffer over night at
4 °C. After several washes in tris-buffered-saline with
Tween (TBST), membranes were incubated with thesecondary antibodies in dilution buffer for 2 h at room
temperature. After several washes, bands were visual-
ized by enhanced chemiluminescence substrate (Super
Signal West Pico, Pierce, USA), and the signals were
recorded by an imaging system (Bio-Rad, USA), and
analyzed with Quantity One software (Bio-Rad, USA).
The primary antibodies were against adiponectin
(Bioworld, BS2833, 1:1000), zinc-α2-glycoprotein (Santa
Cruz, sc-21721, 1:500), TUBB (Bioworld, BS1482MH,
1:10000), and PRKAR2A (Bioworld, BS1929, 1:1000). The
secondary antibodies were goat anti-rabbit horseradish
peroxidase (HRP) antibody (Bioworld, BS13278, 1:10000)
and goat anti-mouse HRP antibody (Bioworld, BS124789,
1:10000).Lipolytic enzymes activity assay
A modification of the procedure of Zhang et al. was used
to extract and assay the lipolytic enzymes [58]. Briefly,
500 mg of frozen adipose tissue in 1 ml of homogenization
buffer (0.1 M K +-PBS containing 1 mM MgCl2, 1 mM
DTT and 1 mM EDTA) was homogenized on ice for
30 min, and then centrifuged at 12,000 × g at 4 °C. The pro-
tein content of supernatants was determined using a BCA
Protein Assay kit (Pierce, Rockford, IL, USA). Triolein
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lyzed to glycerol by lipolytic enzymes. The supernatant
together with prepared triolein were incubated for 1 h at
37 °C. The lipolytic enzymes in supernatant activate the
lypolytic degradation of the triolein emulsion. The released
glycerol was determined using a commercial kit (Applygen,
China). Standard curves were constructed with pure en-
zymes to calculate the activities of the enzymes. All samples
were measured in duplicate at appropriate dilutions.
Radioimmunoassay
The content of leptin in back fat was measured using
a commercial multispecies radioimmunoassay (RIA) kit
(Beijing North Institute of Biotechnology, Beijing, China),
according to the manufacturers’ instructions. A 200 mg fro-
zen back fat sample was minced and homogenized in 1 mL
phosphate buffered saline (PBS). Then, the homogenate
was freeze-dried and redissolved in 200 μL PBS. Finally,
leptin content was measured in this 200 μL solution.
Label-free quantitative proteomics analysis
Another 200 mg back fat sample was weighed and the total
protein was extracted using 1 mL ice-cold homogenization
buffer RIPA containing the protease inhibitor cocktail
(Complete EDTA-free, Roche, Penzberg, Germany). The
same quality (250 μg) for each sample was used for the pro-
teomics analysis. Next, the total protein was digested ac-
cording to the method of filter-aided sample preparation
(FASP) which combines the advantages of in-gel and in-
solution digestion for mass spectrometry–based proteomics
[59]. Then, LC-MS/MS method was used to quantify the
peptide fragments [60]. This experiment was conducted in
College of Life Science in Nanjing Agricultural University.
Finally, the results were analyzed by employing the software
MaxQuant [61]. The proteins which exhibited a change of
at least 2-fold between groups were selected. The data ana-
lysis of the proteome was conducted by BioNovoGene. By
using the software MaxQuant, the number of proteins
identified for each animal in the control group was 817,
610, 616, 679, 575, and 829, respectively; and the number
of proteins identified for each animal in the LPS group was
446, 712, 549, 756, 533, and 744, respectively. Then, accord-
ing to the P-value < 0.05 and fold change > 2 after T test,
we identified 47 regulated proteins.
Statistical analysis
All data are presented as the means ± standard errors.
The statistical analyses were performed using the Statis-
tical Program for Social Sciences (SPSS) software, ver-
sion 20.0, for Windows. The differences were tested via
an analysis of variance (ANOVA), and a t-test was used
for independent samples. Differences with P values < 0.05
were considered statistically significant.Consent
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
images.
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